Impact of early or late intensification of glucose-lowering therapy in patients with type 2 diabetes: the global DISCOVER study

被引：0
|
作者：
Ramirez, L. [1 ]
Ji, L. [2 ]
Bonnet, F. [3 ]
Chen, H. [4 ]
Cooper, A. [5 ]
Hammar, N. [6 ,7 ]
Leigh, P. [5 ]
Saraiva, G. L. [4 ]
Medina, J. [8 ]
Nicolucci, A. [9 ]
Rathmann, W. [10 ]
Shestakova, M. V. [11 ]
Surmont, F. [1 ]
Tang, F. [12 ]
Watada, H. [13 ]
机构：
[1] AstraZeneca, Luton, Beds, England
[2] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[3] Univ Rennes, Rennes, France
[4] AstraZeneca, Gaithersburg, MD USA
[5] AstraZeneca, Cambridge, England
[6] Karolinska Inst, Inst Environm Med, Stockholm, Sweden
[7] AstraZeneca Moldnal, Gothenburg, Sweden
[8] AstraZeneca, Madrid, Spain
[9] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy
[10] Heinrich Heine Univ, Leibniz Inst Diabet Res, German Diabet Ctr, Inst Biometr & Epidemiol, Dusseldorf, Germany
[11] Diabet Inst, Endocrinol Res Ctr, Moscow, Russia
[12] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
[13] Juntendo Univ, Tokyo, Japan
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
295
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [1] Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study
    Ji, Linong
    Bonnet, Fabrice
    Chen, Hungta
    Cooper, Andrew
    Hammar, Niklas
    Leigh, Paul
    Saraiva, Gabriela Luporini
    Ramirez, Larisa
    Medina, Jesus
    Nicolucci, Antonio
    Rathmann, Wolfgang
    Shestakova, Marina, V
    Surmont, Filip
    Tang, Fengming
    Watada, Hirotaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178
  • [2] Inappropriate intensification of glucose-lowering treatment in older patients with type 2 diabetes: the global DISCOVER study
    Bongaerts, Brenda
    Arnold, Suzanne, V
    Charbonnel, Bernard H.
    Chen, Hungta
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia
    Ji, Linong
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Medina, Jesus
    Nicolucci, Antonio
    Shestakova, Marina
    Shimomura, Iichiro
    Tang, Fengming
    Watada, Hirotaka
    Rathmann, Wolfgang
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [3] Quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: the global DISCOVER study
    Nicolucci, A.
    Gomes, M. B.
    Khunti, K.
    Kosiborod, M.
    Pocock, S.
    Rathmann, W.
    Shestakova, M. V.
    Shimomura, I.
    Watada, H.
    Chen, H.
    Cid-Ruzafa, J.
    Fenici, P.
    Hammar, N.
    Tang, F.
    Ji, L.
    DIABETOLOGIA, 2018, 61 : S173 - S174
  • [4] Intensification of glucose-lowering treatment in patients with diabetes mellitus type 2 on insulin therapy: Perspectives of dapagliflozin
    Sukhareva, O. Y.
    Shestakova, M., V
    DIABETES MELLITUS, 2016, 19 (01): : 72 - 79
  • [5] Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
    Bianchi, Cristina
    Daniele, Giuseppe
    Dardano, Angela
    Miccoli, Roberto
    Del Prato, Stefano
    DRUGS, 2017, 77 (03) : 247 - 264
  • [6] Early Combination Therapy with Oral Glucose-Lowering Agents in Type 2 Diabetes
    Cristina Bianchi
    Giuseppe Daniele
    Angela Dardano
    Roberto Miccoli
    Stefano Del Prato
    Drugs, 2017, 77 : 247 - 264
  • [7] Personalizing Glucose-Lowering Therapy in Patients with Type 2 Diabetes and Cardiovascular Disease
    Inzucchi, Silvio E.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 137 - +
  • [8] Hypertension in type 2 diabetes: impact of glucose-lowering medications
    Krentz, Andrew J.
    CARDIOVASCULAR ENDOCRINOLOGY, 2016, 5 (04): : 137 - 143
  • [9] Health-related quality of life in patients with type 2 diabetes initiating a second-line glucose-lowering therapy: The DISCOVER study
    Nicolucci, Antonio
    Chen, Hungta
    Cid-Ruzafa, Javier
    Cooper, Andrew
    Fenici, Peter
    Gomes, Marilia B.
    Hammar, Niklas
    Khunti, Kamlesh
    Kosiborod, Mikhail
    Leigh, Paul
    Medin, Jennie
    Rathmann, Wolfgang
    Shestakova, Marina, V
    Shimomura, Iichiro
    Siddiqui, Afrah
    Tang, Fengming
    Watada, Hirotaka
    Ji, Linong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 180
  • [10] Intensification of polypharmacy glucose-lowering treatment in type-2 diabetes: When to be cautious?
    Charbonnel, Bernard
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (01) : 3 - 5
12345